
Home and Post-Acute Care Software: A Complete Guide
How home health, hospice, SNF and senior living software works: core systems, EVV and assessment rules, value-based payment, interoperability and where AI helps.
How AI for medical diagnosis works, where it is used, how FDA-authorized tools differ from research models, and what evidence to check before you adopt one.

AI for medical diagnosis covers software that detects, classifies or flags disease from medical data: images, physiological signals, lab and pathology results, or a combination. Some of these tools are FDA-authorized medical devices in routine use. Many more are research models that perform well on benchmarks but have not been tested in practice. This guide explains the main types of diagnostic AI, how regulated tools differ from research models, what evidence to look for and how these tools fit into clinical workflows.
Most diagnostic AI is trained on large sets of labeled examples, such as images marked by specialists as showing or not showing a condition. The model learns patterns that link the input to the label, then applies them to new cases. The output is usually a score, a flag, a highlighted region or a recommendation, which a clinician reviews. A small number of tools are authorized to give a result without a specialist reading the image first.
| Type | Input data | Typical tasks | Example |
|---|---|---|---|
| Imaging | X-ray, CT, MRI, ultrasound, retinal images | Detect findings, triage urgent cases, measure structures | IDx-DR for diabetic retinopathy screening; Viz.ai ContaCT for suspected large vessel occlusion stroke |
| Digital pathology | Scanned slide images | Highlight areas likely to contain cancer | Paige Prostate |
| Physiological signals | ECG, EEG and other waveforms | Detect rhythm abnormalities and other patterns | ECG analysis software on the FDA's AI-enabled device list |
| Clinical data and risk prediction | EHR data, labs, vital signs | Flag patients at risk of deterioration or a specific condition | Predictive decision support inside the EHR |
| Multimodal and language models | Text, images and records together | Answer clinical questions, summarize findings | Mostly research, such as Google's Med-PaLM 2 |
Radiology accounts for the largest share of AI devices on the FDA's AI-enabled medical device list. We cover imaging in more depth in our guide to AI in medical imaging.
IDx-DR (2018): FDA described it as the first device authorized to provide a screening decision for diabetic retinopathy without a clinician also interpreting the image, making it usable in primary care (FDA announcement).
Viz.ai ContaCT (2018): analyzes CT images for signs of a suspected large vessel blockage and alerts a specialist. The radiologist still reviews the full scan (FDA announcement).
Paige Prostate (2021): highlights the area of a biopsy image most likely to contain cancer. In FDA's study, pathologists' detection on individual slide images rose from 89.5% to 96.8% with the software (FDA announcement).
Software intended to diagnose or detect disease is generally a medical device. In the US it needs FDA marketing authorization through 510(k), De Novo or premarket approval, and the authorization covers a specific intended use. Software that analyzes medical images or signals stays under FDA oversight even when it only supports a clinician, according to FDA's Clinical Decision Support software guidance.
Research models, including large language models that score well on medical exams, have not been through that process. Benchmark results show what a model can do on a fixed test set. They do not show how it performs on your patients, in your workflow, or over time. Our article on Med-PaLM 2 shows how wide that gap can be.
| Question | Why it matters |
|---|---|
| Is the tool authorized for this exact use and population? | Authorization covers a defined indication, such as a specific scan type and patient group |
| What were sensitivity and specificity, and on which data? | Results depend on the population, scanners and disease prevalence in the study |
| Was it tested on data from sites other than where it was built? | External validation is a better guide to real-world performance |
| How does performance vary by subgroup? | Models can perform worse for groups under-represented in training data |
| Did it change clinical outcomes or workflow? | Accuracy alone does not prove patients benefit |
A diagnostic tool is only useful if its output reaches the right person at the right moment. Imaging AI usually connects to the PACS and reading worklist. Risk prediction connects to the EHR, often through FHIR APIs or decision support standards such as CDS Hooks. Plan for local validation before go-live, clear rules on who acts on an alert, and ongoing monitoring for drift. For predictive tools in certified health IT, ONC's HTI-1 rule requires source attributes such as intended use and performance information to be available to users (ONC HTI-1 final rule). Our article on AI in clinical decision support covers the integration side.
Teams building diagnostic software can see how we approach regulated products on our SaMD solutions page.
AI for medical diagnosis is already in clinical use, mostly in imaging, pathology and signal analysis, and mostly as support for clinicians. The difference between an authorized tool and a promising research model is evidence: a defined intended use, external validation, subgroup results and proof that it works in a real workflow. Ask for that evidence before you adopt or build.
If you are planning a diagnostic AI product or integration, book a consultation with Ekipa's HealthTech engineers.
It analyzes images, slides, physiological signals and clinical data to detect findings, triage urgent cases and flag patients at risk, usually for a clinician to review.
Software intended to diagnose or detect disease is generally a medical device and needs FDA authorization for its specific intended use. Software that analyzes medical images or signals stays under FDA oversight.
A few tools are authorized to do so for narrow tasks. IDx-DR, for example, gives a diabetic retinopathy screening result without a clinician interpreting the image. Most diagnostic AI supports clinicians.
It depends on the tool, task and population. Look for sensitivity, specificity and subgroup results from external validation, and check that the study population matches your patients.
Mostly in research. Some models score well on medical exam questions, but benchmark results do not prove safe performance in clinical practice, and they are not authorized as diagnostic devices.

How home health, hospice, SNF and senior living software works: core systems, EVV and assessment rules, value-based payment, interoperability and where AI helps.

Plan athenahealth API integration step by step: API families, sandbox limits, OAuth flows and production access for smaller healthtech teams.

How EHR integration works: FHIR, HL7 v2 and SMART standards, Epic and Oracle Health programs, migration, prior authorization APIs and the rules that apply.
Connect with our team to explore how AI expertise can transform your business.